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Purpose: Pericardial adipose tissue had been shown to exert local effects on adjacent cardiac 
structures. Data regarding the mechanistic link between such measures and left atrial (LA) 
structural/functional remodeling, a clinical hallmark of early stage heart failure (HF) and atrial 
fibrillation (AF) incidence, in asymptomatic population remain largely unexplored.
Methods: This retrospective analysis includes 356 subjects free from significant valvular 
disorders, atrial fibrillation, or clinical HF. Regional adipose tissue including pericardial and 
periaortic fat volumes, interatrial septal (IAS), and left atrioventricular groove (AVG) fat 
thickness were all measured by multidetector computed tomography (MDCT) (Aquarius 
3D Workstation, TeraRecon, San Mateo, CA, USA). We measured LA volumes, booster 
performance, reservoir capacity as well as conduit function, and analyzed their association 
with adiposity measures.
Results: All four adiposity measures were positively associated with greater LA volumes 
(all P < 0.05), while IAS and AVG fat were also related to larger LA kinetic energy and 
worse reservoir capacity (both P < 0.01). In multivariate models, IAS fat thickness remained 
independently associated with larger LA volumes, increased LA kinetic energy and ejection 
force (β-coef: 0.17 & 0.15, both P < 0.05), and impaired LA reservoir and conduit function 
(β-coef: −0.20 & −0.12, both P < 0.05) after adjusting for clinical variables.
Conclusion: Accumulated visceral adiposity, especially interatrial fat depots, was associated 
with certain LA structural/functional remodeling characterized by impaired LA reservoir 
and conduit function though augmented kinetic energy and ejection performance. Our 
data suggested that interatrial fat burden may be associated with certain detrimental LA 
functions with compensatory LA adaptation in an asymptomatic population.
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Over the past decade, assessment of left atrial (LA) function 
has been shown to be crucial in maintaining adequate 
cardiac mechanistic performance and pump function 
in subjects with preserved left ventricular (LV) systolic 
function with sinus rhythm (1). Throughout the cardiac 
cycle, LA serves multiple roles. First as a reservoir receiving 
pulmonary venous return during ventricular systole, then 
as an open conduit directing the influx of blood flow into 
LV during early diastole, and finally as an active booster 
pump during late diastole (2). It is well-established that 
the reservoir, conduit, and booster functions of LA are key 
 factors to ventricular filling performance, and may serve as 
clinical surrogate of LA dysfunction at an earlier stage (2, 3).
Several clinical risk factors, including obesity, meta-
bolic derangements, and LV hypertrophy secondary to 
chronic pressure overload, had all been shown to affect 
LA structure and function negatively (4). Numerous stud-
ies had demonstrated that the pathogenesis between 
central obesity and cardiovascular diseases (5, 6) may 
be partially mediated by the pericardial adipose tissue, 
a hypothetical source of inflammatory and atherogenic 
cytokines with active biological effects (7, 8). As a result of 
its anatomic proximity and shared blood supply with the 
myocardium, pericardial fat had been reported to influ-
ence various aspects of cardiac function, including LA 
remodeling (9) and the development of atrial fibrillation 
(AF) (10, 11). On the other hand, far less effort had been 
invested in the possible effects that atrial septal fat accu-
mulation (also known as lipomatous septal hypertrophy) 
may impose on specific LA mechanics.
On the basis of this hypothesis, we sought to exam-
ine the link among different sites of visceral adiposity 
with LA structural remodeling and its related mechanistic 
performances in an asymptomatic population. We also 
speculated that visceral fat accumulation surrounding 
interatrial location is associated with some components 




We consecutively studied subjects who received 
cardiovascular health examinations from 2010 to 2013 
at a tertiary medical center in Taipei, Taiwan. The clinical 
setting was for clinical cardiovascular risk stratification 
at cardiovascular outpatient service, which was similar 
to our previously published data (12, 13). All study 
subjects underwent detailed review of medical histories, 
along with physical examination performed in all study 
subjects. Clinical symptoms including angina, chest 
discomfort, or heart failure (e.g. exercise intolerance) were 
all obtained, with subspecialty transferred if appropriate. 
Transthoracic echocardiography, electrocardiography 
(ECG), and cardiac computed tomography (CT) for 
coronary calcium scoring were performed in all subjects. 
Patients with acute decompensated heart  failure 
(HF), unstable angina, atrial flutter/fibrillation (either 
persistent or paroxysmal), severe valvular disease (either 
stenosis or regurgitation), or end-stage renal disease 
were excluded. A total of 356 subjects after exclusion 
during study period were finally enrolled. The presence 
of CAD was defined as a history of previous myocardial 
infarction, previous angioplasty, or more than 50 % 
luminal narrowing diagnosed by coronary angiography. 
Hypertension was defined as systolic blood pressure above 
140 mmHg, diastolic blood pressure above 90 mmHg 
or previously diagnosed hypertension under regular 
medication control. Diabetes was defined as a fasting 
glucose level above 126 mg/dL or previously diagnosed 
diabetes with  medication use. Hyperlipidemia was 
defined as a  history and/or use of lipid-lowering drugs 
such as statins or fibrates on a daily basis. Standardized 
sphygmomanometer cuff-defined resting blood 
pressures were measured at rest by medical staff blinded 
to the other test results. All baseline characteristics and 
information regarding anthropometric measures were 
collected, which included body size in terms of body 
mass index (BMI) and waist circumference.
This study has been approved by Mackay Memorial 
Hospital Institutional Review Board with adherence to 
research ethics (IRB number: 14MMHIS161).
Echocardiography and LA mechanics measures
Each subject underwent two-dimensional (2D) and color 
Doppler transthoracic echocardiography using a commer-
cially available ultrasound system (Vivid 7, GE Medical 
System, Vingmed, Norway) equipped with 2–4 MHz trans-
ducer at the left decubitus position. All recorded images 
were measured and analyzed with clinical information 
blinded using a computerized off-line software (Tom-
Tec Image Arena, Munich, Germany). All measurements 
were averaged from three consecutive cardiac cycles. LV 
wall thickness and mass were determined from M-mode 
method. LV volumes and ejection fraction were obtained 
via the modified biplane Simpson method from the apical 




four- and two-chamber views according to American 
 Society of Echocardiography recommendations (14). 
 Diastolic functional parameters including early mitral 
inflow velocity (E), late mitral inflow velocity (A), decel-
eration time (DT), iso-volumic relaxation time (IVRT), 
and tissue Doppler imaging (TDI)-derived mitral annular 
early-diastolic velocity (eʹ) were all obtained. The average 
eʹ velocity between LV basal septal and lateral segments 
was used for our statistical analysis. Average E/eʹ ratio was 
used to predict LV filling pressures (15).
For volumetric assessment of LA reservoir, conduit, 
and booster functions, maximum LA volume (LAV max, 
at end-systole, just before mitral valve opening), pre-A 
LA volume (LAV pre-A, immediately before atrial con-
traction, marked by the electrocardiographic P-wave), 
and minimum LA volume (LAV min, at end-diastole, 
when the mitral valve closes) were measured by biplane 
method and indexed to body-surface area (14, 16) (Fig. 1). 
LA reservoir function was estimated by expansion index, 
computed as [(LAV max – LAV min)/LAV min] × 100%. 
LA booster function was estimated by active empty-
ing fraction, computed as [(LAV pre-A – LAV min)/LAV 
pre-A] × 100%. LA conduit function was estimated by 
passive emptying fraction, computed as [(LAV max – LAV 
pre-A)/LAV max] × 100% (2). Advanced markers of atrial 
systolic function such as LA ejection force and kinetic 
energy were calculated according to the modified 
 Manning method. LA kinetic energy (kdynes·cm/m2) 
was defined as 0.5 × ρ × LA active emptying volume × A2, 
where ρ was blood density (1.06  g/cm3) and A was 
late-diastolic mitral inflow velocity (cm/s) (17). LA 
 ejection force (kdynes/m2) was defined as (0.5 × ρ × LA 
active  emptying volume × A2)/late-diastolic transmitral 
flow velocity time integral (VTIA, cm) (17). Finally, a subset 
sample of 50 cases was selected for comparing continuous 
speckle tracking analysis and manually traced method for 
echo-defined LA volume data in our lab, which showed high 
correlation (r = 0.96, P < 0.05). To further validate the 
accuracy of our echo-based LA volumes, we randomly 
selected 59 cases who received contrast-enhanced com-
puted tomography (CECT) using multidetector computed 
tomography (MDCT) coronary artery imaging  protocol 
during the study conduction time. LA volumes were 
then quantified and compared with echo-based measures 
which had been approved by research ethics committee.
Quantification of regional pericardial and periaortic fat
All participants had undergone MDCT originally for 
coronary calcium score measurement, and we recon-
structed the images for visceral fat assessment. MDCT 
was performed by using a 16-slice scanner (Sensation 16, 
Siemens Medical Solutions, Forchheim, Germany) with 
16  mm × 0.75  mm collimation, rotation time 420  ms 
and tube voltage of 120 kV. In one breath-hold, images 
were acquired from above the level of tracheal bifurca-
tion to below the base of heart using prospectively ECG 
triggering with the centre of the acquisition at 70% of 
the R-R interval. From the raw data, the images were 
reconstructed with standard kernel in 3 mm thick axial, 
non-overlapping slices and 25 cm field of view.
Visceral adipose tissue measurements were  carried out 
offline (Aquarius iNtuition Cloud, TeraRecon,  SanMateo, 
CA, USA) on a single workstation using methods described 
previously (18). Total pericardial adipose tissue volumes 
were quantified using a semi-automatic segmentation 
technique, in which the region of interest was defined by 
manually tracing the pericardial borders. Fat tissue was 
defined as pixels within a window of −195 to −45 HU, and 
pericardial fat was then selected as adipose tissue within 
the pericardial sac (Fig. 2A). Thoracic periaortic adipose 
tissue was defined as all adipose tissue surrounding the 
thoracic aorta extending 67.5 mm caudally from the level 
of the bifurcation of the pulmonary arteries (Fig. 2B). 
For regional fat thickness measurements, we performed 
multiplanar reconstructions to obtain the standardized 
horizontal long-axis plane from axial and longitudinal 
two-chamber views for subsequent measurement of the 
interatrial septum (IAS) and left atrioventricular groove 
Figure 1
LA volumes measured by biplane area-length method. Volume curve was 
obtained by continuous speckle tracking. Minimum volume (LAV min) is 
measured at the closure of the mitral valve in end-diastole. Maximum 
volume (LAV max) is measured just before the opening of the mitral valve 
in end-systole. Pre-A volume (LAV pre-A) is measured at the onset of the 
P-wave on electrocardiogram.
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(AVG) based on methods validated by a previous study 
(19) (Fig. 2C). For reproducibility assessment, intra-
observer and inter-observer coefficients of variation were 
determined by repeated measurement on 50 randomized 
cases by two experienced readers blinded to the subjects’ 
clinical data. The intra-observer and inter-observer 
coefficients of variation for pericardial fat and interatrial 
fat were 4.27%, 4.87% and 6.58%, 6.81%, respectively.
Statistical analysis
Continuous data were shown as mean with standard 
deviation. Categorical information was expressed as 
the frequency and proportion of prevalence, and then 
compared using a χ2-test or Fisher’s exact test if appropriate. 
Baseline continuous data were compared by a Wilcoxon 
nonparametric test for significant trend across regional 
adipose tissue (IAS) strata based on tertiles. The trend 
between LA/LV structural/functional parameters and 
increasing IAS fat volume was examined across IAS strata, 
with uni- and multi-variable regression models used to 
determine the associations between various regional 
 adipose tissue burden and LA mechanical/functional 
indices (including volumes, booster performance, 
reservoir capacity as well as conduit function).
All data were analyzed using a commercial software 
STATA 8.2 package (Stata Corp, College Station, TX, USA). 
The significance of p level (α-value) for all analysis was 
two-sided, with a value less than 0.05 considered to be 
statistically significant.
Results
Basic information, biomarkers and adiposity measures
The associations of IAS fat with baseline demographics, 
biochemical, or inflammatory markers and other 
Figure 2
(A) 3D-reconstruction of total pericardial fat volume from each axial image (left panel). Pericardial fat (orange shadow) was selected as all adipose tissue 
within the pericardial sac and subtracted from the adjacent cardiac structures (right panel). (B) 3D-reconstruction of thoracic periaortic fat from each 
axial image (left panel). Thoracic periaortic fat (orange shadow) was defined as all adipose tissue surrounding the thoracic aorta extending 67.5 mm 
caudally from the level of the bifurcation of the pulmonary arteries (right panel). (C) Multiplanar reconstructions (red line for each plane) for regional 
fat thickness measurements over the interatrial septum (IAS) and left atrioventricular (AV) groove.




adiposity measures were summarized in Table 1. Among 
all 356 participants, 245 (68.8%) were men, with an 
average age of 51.8 ± 8.8 years. With increasing IAS 
fat measure, there were stepwise increases in BMI and 
waist circumference (trend P < 0.001).  Furthermore, 
increasing fat were significantly associated with 
graded increase in fasting glucose, triglyceride, 
hs-CRP, insulin and insulin resistance (HOMA-IR), 
as well as decreased HDL (all trend P < 0.005). The 
mean total pericardial fat volume and volume index 
were 80.39 ± 26.05  mL, 42.97 ± 13.68  mL/m2, which 
were within the normal limit (125  mL or 68  mL/m2) 
as suggested by a previous literature (20). Mean IAS 
thickness was 5.7 ± 1.71 mm, which was comparable to 
the control group data of a previous study (20). Both 
pericardial and periaortic fat volumes indexed to body-
surface area had significant increase along with increased 
IAS thickness (all P < 0.001). For those subjects without 
any known hypertension, diabetes,  hyperlipidemia or 
coronary artery disease, the mean IAS thickness was 
5.48 ± 1.7 mm (n = 219). A search of our hospital database 
found that 329 (92.4% available) of the participants 
were followed at least once in outpatient clinics. The 
median follow-up period was 3.4 years. Four patients had 
documented atrial fibrillation (AF); two were hospitalized 
for heart failure. Five of those six patients were clustered 
in the third IAS tertile group; the remaining one came 
from the second tertile group (P = 0.025).
Table 1 Relationship of baseline demographics, biochemical and inflammatory markers, medical histories, and other adiposity 
measures with interatrial fat.
Interatrial fat thickness (mm)
P (trend)




Age (years) 50.25 ± 7.90 50.77 ± 9.05 54.09 ± 9.24 0.003
Male (%) 71 (60.17%) 81 (69.23%) 93 (78.15%) 0.007
SBP (mmHg) 119.16 ± 16.76 121.34 ± 16.37 125.15 ± 16.63 0.048
DBP (mmHg) 75.90 ± 10.42 74.91 ± 10.79 77.92 ± 10.47 0.113
BMI (kg/m2) 23.40 ± 2.77 24.49 ± 2.64 25.86 ± 3.00 <0.001
WC (cm) 80.72 ± 8.43 83.42 ± 8.19 89.15 ± 8.06 <0.001
Body fat (%) 25.69 ± 6.70 25.28 ± 6.17 27.86 ± 7.15 0.051
Biochemical data
Fasting glucose (mg/dL) 95.26 ± 11.15 99.81 ± 17.57 104.90 ± 26.21 <0.001
HbA1c (%) 5.84 ± 0.54 5.93 ± 0.59 6.15 ± 1.05 0.079
Cholesterol (mg/dL) 201.04 ± 36.34 198.30 ± 35.07 198.26 ± 36.87 0.786
TG (mg/dL) 122.47 ± 56.54 139.09 ± 88.32 160.07 ± 92.94 0.004
LDL (mg/dL) 133.48 ± 31.30 128.48 ± 33.20 129.93 ± 30.09 0.444
HDL (mg/dL) 51.97 ± 12.89 51.96 ± 14.35 45.69 ± 10.61 0.001
eGFR (mL/min/m2) 85.76 ± 13.70 86.88 ± 16.07 83.22 ± 19.95 0.173
hs-CRP (mg/dL) 0.18 ± 0.16 0.17 ± 0.16 0.33 ± 0.34 <0.001
Insulin (μIU/mL) 5.35 ± 2.87 5.88 ± 3.17 7.17 ± 3.87 0.004
HOMA-IR (IU/mL) 1.24 ± 0.83 1.44 ± 0.92 1.86 ± 1.33 0.001
CCS 145.9 ± 38.51 105.4 ± 21.49 123.52 ± 52.56 0.117
Medical histories
Hyperlipidemia (%) 0.09 ± 0.29 0.14 ± 0.35 0.14 ± 0.35 0.534
Hypertension (%) 0.22 ± 0.42 0.27 ± 0.45 0.34 ± 0.47 0.138
Diabetes (%) 0.08 ± 0.27 0.14 ± 0.35 0.22 ± 0.42 0.008
CAD history (%) 0.01 ± 0.11 0.05 ± 0.22 0.04 ± 0.19 0.337
Adiposity measures
Pericardial fat (mL) 79.25 ± 21.96 83.06 ± 27.96 80.72 ± 29.13 0.539
Pericardial fat index (mL/m2) 28.46 ± 5.91 42.04 ± 5.73 57.69 ± 9.7 <0.001
Periaortic fat (mL) 7.64 ± 3.09 8.49 ± 3.91 8.19 ± 4.14 0.208
Periaortic fat index (mL/m2) 3.19 ± 1.53 4.02 ± 1.51 5.63 ± 2.07 <0.001
Left AVG fat (mm) 3.99 ± 1.02 5.37 ± 0.67 7.42 ± 1.77 <0.001
SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; WC, waist circumference; TG, triglyceride; LDL, low-density lipoprotein; 
HDL, high-density lipoprotein; eGFR, estimated glomerular filtration rate; Hs-CRP, high sensitivity C-reactive protein; HOMA-IR, homeostatic model 
assessment-estimated insulin resistance; CCS, coronary calcium score; CAD, coronary artery disease; AVG, atrioventricular groove.
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Echocardiographic parameters and multivariate analysis
The relationship between IAS fat thickness and various 
LV structural and functional parameters is presented in 
Table 2. Mean LAV max index, LAV pre-A index and LAV 
min index were 18.34 ± 6.04 mL/m2, 10.79 ± 3.75 mL/m2, 
7.5 ± 3.02 mL/m2, respectively. We observed a high corre-
lation between echo and CT-based LA maximum volume 
among 59 random cases in our lab (Echo: 40.6 ± 12.8 ml 
vs CT: 48.6 ±11.5  ml, r = 0.94, P < 0.001), with a mean 
difference of 7.91 ± 4.25 mL (95% CI: −9.02 to −6.81).
Increasing IAS tertiles were associated with graded 
increases in LV wall thickness, chamber size as well as 
total LV mass and LV mass index (all trend P < 0.001), 
whereas global LV systolic function remained relatively 
unaffected. There were no remarkable differences in 
mitral inflow Doppler-derived diastolic functional param-
eters across IAS tertiles, except for a trend towards higher 
A velocity with greater IAS (trend P: 0.018). As for TDI-
derived parameters, there were significant reductions in 
average e’ velocity (trend P: 0.014) and increases in E/e’ 
ratio (trend P: 0.001).
We showed that greater IAS fat was strongly related 
to all three volume indices (1st vs 3rd tertiles: 16.85 vs 
19.87  mL/m2 for LAV max index, 9.73 vs 12.03 mL/m2 
for LAV pre-A index, 6.68 vs 8.61 mL/m2 for LAV min 
index, all P < 0.05) (Table 3). With each increasing IAS 
Table 3 Relationship of LA structural/functional parameters with interatrial fat.
Interatrial fat thickness (mm)
1st tertile group 2nd tertile group 3rd tertile group
2.00–2.48 4.83–6.36 6.37–10.8
(n = 119) (n = 119) (n = 118) P (trend)
LAV max index (mL/m2) 16.85 ± 5.53 18.37 ± 6.03 19.87 ± 6.23¥ 0.001
LAV pre-A index (mL/m2) 9.73 ± 3.20 10.65 ± 3.55 12.03 ± 4.17¥※ <0.001
LAV min index (mL/m2) 6.68 ± 2.55 7.27 ± 2.65 8.61 ± 3.51¥※ <0.001
LA reservoir function/expansion index (%) 159.44 ± 46.64 157.94 ± 45.65 142.4 ± 40.8¥※ 0.004
LA booster function/active emptying fraction (%) 31.94 ± 7.37 31.92 ± 6.71 29.72 ± 6.52¥※ 0.022
LA conduit function/passive emptying fraction (%) 41.84 ± 5.77 41.59 ± 6.03 39.97 ± 5.58¥ 0.009
LA kinetic energy (kdynes·cm/m2) 5.84 ± 2.56 7.13 ± 3.55¥ 7.75 ± 3.84¥ <0.001
LA ejection force (kdynes/m2) 1.12 ± 0.41 1. 26 ± 0.46¥ 1.29 ± 0.43¥ 0.001
LAV max, LA maximum volume; LAV pre-A, LA pre-A volume; LAV min, LA minimum volume.
¥P < 0.05 versus 1st tertile group by ANOVA.
※P < 0.05 versus 2nd tertile group by ANOVA.
Table 2 Relationship of LV structural/functional parameters with interatrial fat.
Interatrial fat thickness (mm)
1st tertile group 2nd tertile group 3rd tertile group
2.00–2.48 4.83–6.36 6.37–10.8
(n = 119) (n = 119) (n = 118) P (trend)
IVS (mm) 9.33 ± 1.22 9.60 ± 1.15 10.14 ± 1.15 <0.001
PWT (mm) 9.03 ± 1.20 9.50 ± 1.22 9.99 ± 1.10 <0.001
LVEDV (mL) 96.58 ± 14.87 102.68 ± 15.22 109.32 ± 16.68 <0.001
LVESV (mL) 30.93 ± 7.35 32.89 ± 6.94 34.87 ± 7.85 <0.001
LVM (gm) 141.90 ± 33.70 156.82 ± 34.22 175.31 ± 39.15 <0.001
LVMI (gm/m2) 77.83 ± 15.89 83.23 ± 14.88 89.21 ± 16.60 <0.001
LVEF (%) 68.95 ± 2.76 68.56 ± 3.74 68.29 ± 3.46 0.463
E (cm/s) 61.51 ± 14.91 61.57 ± 13.48 60.51 ± 16.76 0.637
A (cm/s) 60.56 ± 12.28 62.59 ± 12.69 66.18 ± 15.82 0.018
DT (ms) 204.36 ± 45.60 206.94 ± 51.67 211.69 ± 48.49 0.383
IVRT (ms) 91.44 ± 15.92 93.34 ± 14.32 94.89 ± 17.36 0.121
eʹ (cm/s) 10.2 ± 2.66 8.76 ± 3.02 7.8 ± 2.04 0.014
E/eʹ 7.17 ± 2.21 7.9 ± 4.03 8.49 ± 3.19 0.001
IVS, interventricular septum; PWT, posterior wall thickness; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; 
LVM, left ventricular mass; LVMI, left ventricular mass index; LVEF, left ventricular ejection fraction; E, early mitral inflow velocity; A, late mitral inflow 
velocity; DT, deceleration time; IVRT, isovolumetric relaxation time; eʹ, early-diastolic tissue velocity.




tertile, there was a significant decrease in all three func-
tional parameters (1st vs 3rd tertiles: 159.44 vs 142.4% 
for reservoir function/expansion index, 31.94 vs 29.72% 
for booster function/active emptying fraction, 41.84 vs 
39.97% for conduit function/passive emptying  faction, 
all P < 0.05). However, both LA kinetic energy and 
ejection force had graded increases (1st vs 3rd  tertiles: 
5.84 vs 7.75 kdynes·cm/m2 for LA kinetic energy, 
Table 4 Univariate and multivariate models regarding the differential association between LA structural/functional parameters 


























Pericardial fat 0.11* 0.14** 0.14* –0.07 0.07 0.13* 0.07 0.05
Periaortic fat 0.12* 0.13* 0.13* –0.06 0.08 0.18*** 0.06 0.05
Left AVG fat 0.15** 0.19*** 0.18** –0.15** 0.10 0.10 0.17** 0.10
IAS fat 0.22*** 0.32*** 0.30*** –0.19*** –0.13* –0.15** 0.18*** 0.14***
Model 2
Pericardial fat 0.09 0.12* 0.12* –0.05 0.08 0.12* 0.06 0.05
Periaortic fat 0.11* 0.11* 0.11* –0.03 0.08 0.17** 0.04 0.04
Left AVG fat 0.14*** 0.16** 0.15** –0.11* 0.11 0.09 0.14* 0.08
IAS fat 0.21 0.29*** 0.29*** –0.16** 0.14** –0.13* 0.17** 0.13*
Model 3
Pericardial fat 0.05 0.09 0.09 –0.05 0.04 0.07 0.05 0.04
Periaortic fat 0.09 0.07 0.08 0.01 0.07 0.15* 0.02 0.02
Left AVG fat 0.09 0.10 0.11 –0.11 0.08 0.08 0.17* 0.10
IAS fat 0.19** 0.30*** 0.29*** –0.20* –0.13 –0.12* 0.17* 0.15*
LAV max, LA maximum volume; LAV pre-A, LA pre-A volume; LAV min, LA minimum volume; AVG, atrioventricular groove; IAS, interatrial septum.
Model 1: Univariate.
Model 2: Multivariate: adjusted for age, gender.
Model 3: Multivariate: adjusted for age, gender, eGFR, LV mass, history of hypertension, diabetes, hyperlipidemia or CAD.
*P < 0.05; **P < 0.01; ***P < 0.001.
Figure 3
Linear regression plots of (A) left atrial reservoir function, (B) booster function, (C) conduit function, (D) kinetic energy (E) and ejection force in relation to IAS 
thickness. The fitted lines point to a gradual decline in all three functional indices and increases in both LA kinetic energy and ejection force (all P < 0.001).
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1.12 vs 1.29 kdynes/m2 for LA ejection force, both 
P < 0.05). Figure   3 shows the linear regression analysis 
and scatter plots for the afore-mentioned parameters 
in relation to IAS fat thickness. The fitted lines point 
to a gradual decline in all three functional indices and 
increases in both LA kinetic energy and ejection force 
(all P < 0.001).
Table 4 presents both univariate and multivariate 
models regarding the differential association between 
LA structural/functional parameters and regional fat 
measures. In univariate analysis, both IAS and left AVG 
fat thickness were significantly related to increased LA 
volumes, impaired LA reservoir function (β-coef: −0.15, 
P < 0.01 for AVG fat; β-coef: −0.19, P < 0.001 for IAS fat), 
and increased kinetic energy (β-coef: 0.17, P < 0.01 for 
AVG fat; β-coef: 0.18, P < 0.001 for IAS fat). In addition, 
thicker IAS fat was also associated with decreased LA 
booster function (β-coef: −0.13, P < 0.05), conduit func-
tion (β-coef: −0.15, P < 0.01), and increased ejection force 
(β-coef: 0.14, P < 0.001). In the multivariate analysis, 
IAS fat thickness remained significantly associated with 
increased LA volumes (β-coef: 0.19, 0.3, 0.29, respectively, 
all P < 0.01), increased LA kinetic energy and ejection force 
(β-coef: 0.17 & 0.15, respectively, both P < 0.05), impaired 
LA reservoir and conduit function (β-coef: −0.2 & −0.12, 
respectively, both P < 0.05) after adjusting for age, gender, 
eGFR, LV mass, and history of hypertension, diabetes, 
hyperlipidemia or CAD.
Discussion
In this study, we observed that regional adiposity in terms 
of interatrial fat was partially associated with  several 
LV geometric alterations and diastolic dysfunction. 
 Furthermore, greater IAS was associated with LA structural 
and functional adaptations including LA enlargement, 
attenuated reservoir, conduit and booster performance, 
yet globally enhanced kinetic energy and ejection force. 
After control of multiple variables, these associations 
remained mostly significant except for booster function.
Potential mechanisms for the association of interatrial 
fat and atrial function
Lipomatous septal hypertrophy is a well-documented 
clinical condition associated with sick sinus syndrome 
(21) and atrial arrhythmias (22, 23, 24). Previous  studies 
based on both necropsy (25) and image data (19, 26) had 
confirmed that these fatty infiltrates in the interatrial 
septum are proportionately correlated with total pericar-
dial fat volume and one-dimensional fat thickness over 
grooved segments. In a previous study by Shin et al. [19], 
after dividing 160 patients into persistent AF, paroxys-
mal AF and control groups, the authors demonstrated 
that increased interatrial fat thickness was associated 
with AF severity. However, to the best of our knowledge, 
no investigation had yet been aimed specifically at the 
mechanistic link between interatrial fat and LA structural 
remodeling and functional alterations.
It has been previously reported that pericardial fat was 
independently associated with metabolic derangements, 
fatty liver disease, insulin resistance and systemic inflam-
mation, by utilizing CT measures (13, 27). Histological 
studies of lipomatous septal hypertrophy have shown an 
abundance of inflammatory cells and fibrosis permeating 
throughout the fatty infiltrates (25). It has also been sug-
gested that certain cytokines and inflammation  process 
from accumulated adiposity may have direct adverse 
effects on LA mechanics or mediated arrhythmogenesis 
(19, 26, 28), leading to consequent structural  remodeling, 
conduction disturbances and AF incidence (29). This study 
compared the associations among LA regional  adiposity, 
pericardial, periaortic fat, and several LA structural/ 
functional measures respectively. Since only interatrial 
fat had significant correlations with LA functions after 
 multivariate adjustment, this may imply that interatrial fat 
should be viewed as a separate entity from pericardial fat. 
In contrast, AV groove fat may be regarded an extension of 
pericardial fat by sharing similar characteristics. While the 
enveloping pericardial fat may affect global cardiac func-
tion by both mechanical compression and cytokine secre-
tion, the different anatomic nature of interatrial septal fat 
suggests a more biochemically oriented pathway.
Previous studies on patients with mild-to-moderate heart 
failure symptoms have shown that higher LA contractile or 
ejection force and greater kinetic energy may exist in these 
patients compared with healthy people (17, 30), possibly as 
compensation for maintaining resting cardiac output (31, 
32). Our study showed that greater fat depots surrounding 
LA, especially interatrial fat, was accompanied by decreased 
reservoir function though augmented LA kinetic energy 
and ejection force. This supports the concept that such 
regional adipose tissues can be beneficial by preserving 
myocardial energy  supply under certain circumstances, yet 
simultaneously impose certain negative effects generated 
by inflammatory process. Similar paradoxical effects of 
central  obesity have been widely explored in previous 
literature (33, 34, 35). Investigators had previously observed 
an early reduction in LA reservoir and conduit functions 




along with compensatory increase in contractile function 
among patients with either hypertension (36, 37) or heart 
 failure with preserved ejection fraction (32), possibly at the 
expense of LA enlargement. Another reason for LA  volume 
expansion was believed to result from compensatory 
increased preload as a result of the optimal use of 
Frank–Starling mechanism to provoke atrial muscle 
shortening and contractility for same reasons (38). Taken 
together, our findings can be interpreted as subclinical LA 
functional disturbances possibly driven by the detrimental 
effects of interatrial fat, leading to impaired LA reservoir and 
conduit functions. On the meanwhile, cardiac performance 
was preserved by LA enlargement and augmented LA 
ejection force and kinetic energy in this process.
Potential clinical implications
A previous study showed that individuals without AF 
history who had increased atrial fat infiltration may be 
exposed to higher risk of developing AF, according to the 
ARIC risk score. They also found that IAS width strongly 
correlated with the extent of atrial fat infiltration (39). So 
far, impaired LA reservoir and conduit functions in indi-
viduals with central obesity or metabolic derangements 
had been speculated to be associated with AF substrate 
formation (10, 11), which may be independent of LA size 
(40). While different “weight” of various sites adiposity 
on cardiac structure/functions or electrical properties 
may exist (8, 9, 28), we and others demonstrated that 
IAS fat infiltrate may be of potential clinical significance 
(19, 38). In particular, as reported before, higher preva-
lence of atrial arrhythmias (for instance, AF) and overt 
LA remodeling had been observed with lipomatous 
septal hypertrophy (24). Compared with other fat depots, 
interatrial fat burden was more strongly linked to dete-
riorated LA mechanics of several aspects in our work after 
accounting for clinical covariates. An in-depth under-
standing of such findings may therefore help to identify 
a specific population at higher risk of AF development in 
daily practice. Thus, we speculate that early prevention 
of such fat infiltration or aggressive control of underlying 
clinical risks might prevent AF development, which may 
require further confirmation in future research.
Limitations
There are several limitations in our study. The first, our 
study has a male gender predominance, which may 
be somewhat biased. Secondly, this survey is mainly 
retrospective and cross-sectional, without an elaborate 
longitudinal follow-up of clinical outcomes. The actual 
number of patients who developed AF or heart failure was 
very low. This could be partially explained by the practice 
of national health insurance, which mandates nearly full 
population coverage in general disease management. 
However, the lack of ambulatory ECG monitoring 
rendered it impossible to determine whether silent 
paroxysmal arrhythmias might be missed. Thirdly, we 
primarily assessed LA volume by 2D echocardiography 
at specific time points, which is limited in accuracy due 
to the left atrium’s complex geometry and surrounding 
structures. Data of advanced imaging techniques such as 
speckle tracking and 3D-based echocardiography were also 
 limited. However, we also performed CT measurements on 
nearly one-sixths of the study population, and the high 
correlation suggested that the echocardiographic method 
can be validated. Finally, although most data from our 
analysis had high statistical significance, the actual 
correlation was not strong, indicating that interatrial fat 
is only a minority in the wide range of multiple factors 
accounting for variations in LA mechanics.
Conclusions
This study showed that in an asymptomatic population, 
regional adipose tissue may have a negative impact on 
the LV geometry and LA remodeling process, which 
primarily manifested as LA enlargement accompanied 
by functional decline of several LA mechanics, including 
conduit and reservoir functions. These remodeling 
processes were associated with increased LA global kinetic 
energy and  ejection force at the hemodynamic level, 
which may serve to compensate for those functional 
deteriorations of LA in asymptomatic population. More 
studies may be required to determine whether this 
association with LA function was mainly a causative of 
interatrial fat deposition, or vice versa.
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